CINFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug CINFLOX contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0029	Tablet	CINFLOX 500 TABLETS TAB 500 mg 1X10	CINFLOX 500 TABLETS (CIPROFLOXACIN HYDROCHLORIDE 500MG) CINFLOX 500 TABLETS (CIPROFLOXACIN HYDROCHLORIDE 500MG) EACH FILM-COATED CAPLET CONTAINS: CIPROFLOXACIN HCL U.S.P. EQUIVALENT TO CIPROFLOXACIN 500MG B4-0029 Drugs Imported Products 1X10 Over The Counter (OTC) 28/06/2023 ORJI PHARMACEUTICAL COMPANY LIMITED, 15, OKEY EJEKUBI, MOSAFEJO, OJO LAGOS LAGOS 80356919 orjipharmaceutical@yahoo.com M/S SHANDONG XIER KANGTAI PHARM. CO. LTD, PRIVATE ECONOMY GARDEN, XINYAN TOWN, JANZHOU, JINING CITY, SHANDONG, CHINA., China	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0029